SCART1
gene geneOn this page
Also known as CD163c-alpha
Summary
SCART1 (scavenger receptor family member expressed on T cells 1, HGNC:32411) is a protein-coding gene on chromosome 10q26.3, encoding Scavenger receptor cysteine-rich domain-containing protein SCART1 (Q4G0T1). May play a role in the immune system, perhaps as a co-receptor on alphabeta and gammadelta T-cells.
Predicted to be involved in T cell mediated immunity. Located in brush border and cytoplasm.
Source: NCBI Gene 619207 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001396050
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32411 |
| Approved symbol | SCART1 |
| Name | scavenger receptor family member expressed on T cells 1 |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CD163c-alpha |
| Ensembl gene | ENSG00000214279 |
| Ensembl biotype | protein_coding |
| Entrez | 619207 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 retained_intron, 1 protein_coding
ENST00000462252, ENST00000463137, ENST00000475114, ENST00000482993, ENST00000488261, ENST00000640237
RefSeq mRNA: 1 — MANE Select: NM_001396050
NM_001396050
CCDS: CCDS91391
Canonical transcript exons
ENST00000640237 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001628808 | 133457279 | 133457575 |
| ENSE00003802017 | 133459021 | 133459326 |
| ENSE00003803573 | 133456237 | 133456554 |
| ENSE00003805075 | 133458360 | 133458656 |
| ENSE00003805472 | 133466235 | 133466381 |
| ENSE00003805698 | 133459487 | 133460170 |
| ENSE00003806019 | 133465106 | 133465174 |
| ENSE00003807120 | 133465251 | 133465565 |
| ENSE00003807709 | 133464606 | 133464911 |
| ENSE00003809737 | 133467198 | 133467353 |
| ENSE00003978156 | 133467847 | 133469760 |
| ENSE00003978157 | 133453945 | 133454064 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 81.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3231 / max 66.2479, expressed in 89 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 107803 | 0.3060 | 88 |
| 107802 | 0.0171 | 5 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 81.95 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.98 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.53 | gold quality |
| esophagus mucosa | UBERON:0002469 | 72.14 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 71.76 | gold quality |
| body of pancreas | UBERON:0001150 | 71.39 | gold quality |
| body of uterus | UBERON:0009853 | 70.99 | gold quality |
| body of stomach | UBERON:0001161 | 70.95 | gold quality |
| granulocyte | CL:0000094 | 70.85 | gold quality |
| right adrenal gland | UBERON:0001233 | 70.38 | gold quality |
| popliteal artery | UBERON:0002250 | 70.21 | gold quality |
| tibial artery | UBERON:0007610 | 70.21 | gold quality |
| esophagus | UBERON:0001043 | 70.15 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 70.09 | gold quality |
| right lobe of liver | UBERON:0001114 | 70.04 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 69.37 | gold quality |
| metanephros cortex | UBERON:0010533 | 69.28 | gold quality |
| spleen | UBERON:0002106 | 69.24 | gold quality |
| aorta | UBERON:0000947 | 69.20 | gold quality |
| sural nerve | UBERON:0015488 | 69.14 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 69.03 | gold quality |
| skin of abdomen | UBERON:0001416 | 68.86 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 68.83 | gold quality |
| left adrenal gland | UBERON:0001234 | 68.61 | gold quality |
| bone marrow cell | CL:0002092 | 68.55 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 68.46 | gold quality |
| left coronary artery | UBERON:0001626 | 68.45 | gold quality |
| right frontal lobe | UBERON:0002810 | 68.45 | gold quality |
| lower esophagus | UBERON:0013473 | 68.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.29 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- the characterization of hSCART1 at the mRNA and protein level suggests that the protein plays a role in the immune system, perhaps as a co-receptor on alphabeta and gammadelta T cells. (PMID:22795646)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Scart2 | ENSMUSG00000054672 |
| rattus_norvegicus | Or12j2 | ENSRNOG00000036647 |
Paralogs (15): CD6 (ENSG00000013725), CD5L (ENSG00000073754), LGALS3BP (ENSG00000108679), CD5 (ENSG00000110448), LOX (ENSG00000113083), LOXL3 (ENSG00000115318), LOXL1 (ENSG00000129038), LOXL2 (ENSG00000134013), LOXL4 (ENSG00000138131), SSC4D (ENSG00000146700), PRSS12 (ENSG00000164099), CD163 (ENSG00000177575), CD163L1 (ENSG00000177675), SSC5D (ENSG00000179954), DMBT1 (ENSG00000187908)
Protein
Protein identifiers
Scavenger receptor cysteine-rich domain-containing protein SCART1 — Q4G0T1 (reviewed: Q4G0T1)
Alternative names: Scavenger receptor family member expressed on T cells 1
All UniProt accessions (1): Q4G0T1
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in the immune system, perhaps as a co-receptor on alphabeta and gammadelta T-cells.
Subcellular location. Membrane.
Tissue specificity. Mainly expressed by CD4(+) and CD8(+) T lymphocytes. Also highly expressed in small intestine and colon. Expressed (at protein level) in small intestine, stomach, gall bladder, and placental villi.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q4G0T1-1 | 1 | yes |
| Q4G0T1-2 | Gamma | |
| Q4G0T1-3 | Alpha |
RefSeq proteins (1): NP_001382979* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001190 | SRCR | Domain |
| IPR036772 | SRCR-like_dom_sf | Homologous_superfamily |
Pfam: PF00530
UniProt features (40 total): disulfide bond 18, domain 8, splice variant 4, glycosylation site 3, topological domain 2, sequence conflict 2, signal peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4G0T1-F1 | 70.15 | 0.17 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (18): 53–117, 66–127, 97–107, 160–216, 171–226, 196–206, 253–315, 266–325, 297–307, 353–417, 366–427, 397–407, 472–533, 503–513, 594–655, 625–635, 824–885, 855–865
Glycosylation sites (3): 94, 129, 332
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 51 (showing top):
GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_LEUKOCYTE_MEDIATED_IMMUNITY, CADWELL_ATG16L1_TARGETS_DN, GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY, GOBP_ADAPTIVE_IMMUNE_RESPONSE, GOBP_IMMUNE_EFFECTOR_PROCESS, GOBP_T_CELL_LINEAGE_COMMITMENT, GOBP_T_CELL_MEDIATED_IMMUNITY, GOBP_CELL_FATE_COMMITMENT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS, GOCC_APICAL_PART_OF_CELL, GAVIN_FOXP3_TARGETS_CLUSTER_T7, GAVIN_FOXP3_TARGETS_CLUSTER_P3, GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS
GO Biological Process (2): T cell mediated immunity (GO:0002456), immune system process (GO:0002376)
GO Molecular Function (0):
GO Cellular Component (4): cytoplasm (GO:0005737), plasma membrane (GO:0005886), brush border (GO:0005903), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| lymphocyte mediated immunity | 1 |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1 |
| biological_process | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| microvillus | 1 |
| apical part of cell | 1 |
| cluster of actin-based cell projections | 1 |
Protein interactions and networks
STRING
532 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCART1 | OR7A17 | O14581 | 479 |
| SCART1 | FUOM | A2VDF0 | 420 |
| SCART1 | CYP4V2 | Q6ZWL3 | 364 |
| SCART1 | LDLRAD2 | Q5SZI1 | 359 |
| SCART1 | CD5 | P06127 | 352 |
| SCART1 | SOX13 | Q9UN79 | 308 |
| SCART1 | HP | P00737 | 290 |
| SCART1 | FHOD1 | Q9Y613 | 286 |
| SCART1 | BMP1 | P13497 | 282 |
| SCART1 | HPR | P00739 | 273 |
| SCART1 | IL17A | Q16552 | 272 |
| SCART1 | TLL1 | O43897 | 254 |
| SCART1 | PRAP1 | Q96NZ9 | 250 |
| SCART1 | IL2RB | P14784 | 245 |
| SCART1 | CCR6 | P51684 | 238 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPC3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A1L0T3, A1L4H1, D3ZTE0, G3V801, O08762, O43866, O75636, O95428, O97507, P00748, P22457, P56730, P58215, P69525, P69526, P85521, P98140, Q02853, Q04756, Q04962, Q24K22, Q2VL90, Q2VLG4, Q2VLG6, Q2VLH6, Q499S5, Q4G0T1, Q5G265, Q5G268, Q5G269, Q5G270, Q5G271, Q5IJ48, Q6QNF4, Q70UZ7, Q769J6, Q76LX8, Q7Z410, Q80YA8, Q80YC5
Diamond homologs: A1L0T3, A1L1V4, A1L4H1, A5PJQ2, A6H737, A7E3W2, B4F6N6, B5DF27, B8A4W9, E1C3U7, F1QQC3, F1RD85, F7J220, G3V801, M9NDE3, O08762, O43866, O70513, P21757, P21758, P30203, P30204, P30205, P56730, P58022, P58215, P70117, P85521, Q05585, Q07797, Q08380, Q08B63, Q14DK5, Q24JV9, Q2VL90, Q2VLG4, Q2VLG6, Q2VLH6, Q4A3R3, Q4G0T1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
171 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:133520550:G:GT | donor_gain | 0.9700 |
| 10:133520557:C:T | donor_gain | 0.9600 |
| 10:133520630:TG:T | donor_gain | 0.9600 |
| 10:133520653:A:G | donor_gain | 0.9600 |
| 10:133520479:G:GT | donor_gain | 0.9500 |
| 10:133520631:G:GT | donor_gain | 0.9500 |
| 10:133520715:G:GT | donor_gain | 0.9500 |
| 10:133520561:GTT:G | donor_gain | 0.9400 |
| 10:133520562:T:G | donor_gain | 0.9400 |
| 10:133520631:GA:G | donor_gain | 0.9400 |
| 10:133520632:AA:A | donor_gain | 0.9400 |
| 10:133520557:CGAG:C | donor_loss | 0.9300 |
| 10:133520558:GAGG:G | donor_loss | 0.9300 |
| 10:133520560:GGTTG:G | donor_loss | 0.9300 |
| 10:133520561:GTTGT:G | donor_loss | 0.9300 |
| 10:133520512:G:GT | donor_gain | 0.9200 |
| 10:133520629:GTGAA:G | donor_gain | 0.9100 |
| 10:133520513:G:GT | donor_gain | 0.9000 |
| 10:133520513:G:T | donor_gain | 0.9000 |
| 10:133521014:TC:T | donor_gain | 0.8900 |
| 10:133520510:C:T | donor_gain | 0.8800 |
| 10:133520558:G:GT | donor_gain | 0.8600 |
| 10:133520634:G:GG | donor_gain | 0.8500 |
| 10:133520533:GC:G | donor_gain | 0.8400 |
| 10:133520617:T:TA | donor_gain | 0.8300 |
| 10:133521010:G:T | donor_gain | 0.8200 |
| 10:133520633:A:AG | donor_gain | 0.8000 |
| 10:133520618:C:CA | donor_gain | 0.7900 |
| 10:133520620:T:G | donor_gain | 0.7800 |
| 10:133520628:A:AG | donor_gain | 0.7800 |
AlphaMissense
6543 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:133456340:G:C | W57C | 0.998 |
| 10:133456340:G:T | W57C | 0.998 |
| 10:133459112:G:C | W357C | 0.996 |
| 10:133459112:G:T | W357C | 0.996 |
| 10:133459590:G:C | W463C | 0.994 |
| 10:133459590:G:T | W463C | 0.994 |
| 10:133456338:T:A | W57R | 0.993 |
| 10:133456338:T:C | W57R | 0.993 |
| 10:133458424:G:C | W249C | 0.988 |
| 10:133458424:G:T | W249C | 0.988 |
| 10:133459566:G:C | W455C | 0.986 |
| 10:133459566:G:T | W455C | 0.986 |
| 10:133456367:C:G | C66W | 0.984 |
| 10:133457406:C:G | C171W | 0.984 |
| 10:133459738:T:A | C513S | 0.984 |
| 10:133459739:G:C | C513S | 0.984 |
| 10:133456365:T:A | C66S | 0.983 |
| 10:133456366:G:A | C66Y | 0.983 |
| 10:133456366:G:C | C66S | 0.983 |
| 10:133457405:G:A | C171Y | 0.983 |
| 10:133458550:G:C | W291C | 0.983 |
| 10:133458550:G:T | W291C | 0.983 |
| 10:133459137:T:A | C366S | 0.983 |
| 10:133459138:G:C | C366S | 0.983 |
| 10:133456458:T:A | C97S | 0.981 |
| 10:133456459:G:C | C97S | 0.981 |
| 10:133458566:T:A | C297S | 0.981 |
| 10:133458567:G:C | C297S | 0.981 |
| 10:133456380:T:A | C71S | 0.980 |
| 10:133456381:G:C | C71S | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1000042474 (10:133463850 G>A), RS1000191074 (10:133469190 G>A,C), RS1000263474 (10:133461205 G>A,C), RS1000441425 (10:133456833 C>A,G,T), RS1000499098 (10:133464277 G>A,T), RS1000763004 (10:133453666 G>A), RS1000802462 (10:133457069 G>C), RS1000871510 (10:133453866 G>A,T), RS1001231008 (10:133456801 G>A), RS1001344040 (10:133452470 T>G), RS1001438952 (10:133460799 T>G), RS1001558355 (10:133465968 C>A), RS1001822574 (10:133456417 T>C), RS1001853926 (10:133456541 C>T), RS1002602567 (10:133465961 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| methyleugenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Smoke | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.